Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-08-29 14:17Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 42.36 yuan, reflecting a 1.17% increase as of August 29, 2025, despite a net outflow of main funds [1][2]. Financial Performance - Steady Medical reported a main revenue of 5.296 billion yuan for the first half of 2025, representing a year-on-year increase of 31.31% [3]. - The net profit attributable to shareholders was 492 million yuan, up 28.07% year-on-year, while the net profit after deducting non-recurring gains and losses was 461 million yuan, increasing by 40.9% [3]. - In Q2 2025, the company achieved a single-quarter main revenue of 2.691 billion yuan, a 26.66% increase year-on-year, and a net profit of 243 million yuan, up 20.68% [3]. Market Position - Steady Medical's total market capitalization is 24.667 billion yuan, ranking 4th in the beauty and personal care industry [3]. - The company has a net asset of 12.276 billion yuan, ranking 1st in the industry, and a net profit of 492 million yuan, ranking 3rd [3]. - The company's price-to-earnings ratio (P/E) is 25.07, which is lower than the industry average of 31.93, ranking 3rd [3]. Fund Flow Analysis - On August 29, 2025, the main funds experienced a net outflow of 47.5893 million yuan, accounting for 6.42% of the total transaction amount [1][2]. - Retail investors showed a net inflow of 48.1353 million yuan, representing 6.49% of the total transaction amount on the same day [1][2]. - Over the past five days, the stock has seen fluctuations in fund flows, with varying levels of net inflows and outflows from main and retail investors [2]. Institutional Ratings - In the last 90 days, 20 institutions have rated the stock, with 17 buy ratings and 3 hold ratings [4]. - The average target price set by institutions over the past 90 days is 55.82 yuan [4].